Development of PEGylated KMnF3 nanoparticles as a T1-weighted contrast agent: chemical synthesis, in vivo brain MR imaging, and accounting for high relaxivity.
about
Development of PEGylated KMnF3 nanoparticles as a T1-weighted contrast agent: chemical synthesis, in vivo brain MR imaging, and accounting for high relaxivity.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Development of PEGylated KMnF3 ...... ccounting for high relaxivity.
@ast
Development of PEGylated KMnF3 ...... ccounting for high relaxivity.
@en
type
label
Development of PEGylated KMnF3 ...... ccounting for high relaxivity.
@ast
Development of PEGylated KMnF3 ...... ccounting for high relaxivity.
@en
prefLabel
Development of PEGylated KMnF3 ...... ccounting for high relaxivity.
@ast
Development of PEGylated KMnF3 ...... ccounting for high relaxivity.
@en
P2093
P2860
P356
P1433
P1476
Development of PEGylated KMnF3 ...... ccounting for high relaxivity.
@en
P2093
Xiao-xia Song
Zhi-jun Liu
P2860
P304
P356
10.1039/C3NR00721A
P407
P577
2013-05-02T00:00:00Z